Oligonucleotide Synthesis Market Report 2022: Small Biotechs in a Position to Become Huge Multinationals
July 06, 2022 04:03 ET
|
Research and Markets
Dublin, July 06, 2022 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides and including Customized...
Antisense Oligonucleotide (ASO) Therapeutics Market Report Up to 2031, By Visiongain Research Inc
April 19, 2022 10:00 ET
|
Visiongain Ltd
Visiongain has launched a new report Antisense Oligonucleotide (ASO) Therapeutics Market Report 2021-2031: Forecasts by Therapeutic Area (Genetic Disorders, Neurological Disorders, Oncological...
Outlook on the Oligonucleotide Synthesis Global Market - Featuring Abbott Diagnostics, Amyris and Bayer Among Others
February 03, 2022 04:38 ET
|
Research and Markets
Dublin, Feb. 03, 2022 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides and including Customized...
Global Oligonucleotide Synthesis Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
December 16, 2021 06:08 ET
|
Research and Markets
Dublin, Dec. 16, 2021 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Global RNA Targeting Small Molecules Therapeutics Market Research Report 2021 with Analysis & Forecasts to 2030
November 09, 2021 06:18 ET
|
Research and Markets
Dublin, Nov. 09, 2021 (GLOBE NEWSWIRE) -- The "RNA Targeting Small Molecules Therapeutics Market by Type of Target Molecule, Type of Approach, Target Indication, Target Therapeutic Area, Route of...
Antisense Oligonucleotide Therapeutics Pipeline Insight Report 2021: Focus on 15+ Companies and 15+ Pipeline Drugs
October 18, 2021 11:23 ET
|
Research and Markets
Dublin, Oct. 18, 2021 (GLOBE NEWSWIRE) -- The "Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2021" clinical trials has been added to ResearchAndMarkets.com's offering. This "Antisense...
Outlook on the mRNA Global Market and Therapeutics to 2026
October 06, 2021 06:43 ET
|
Research and Markets
Dublin, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The "mRNA: Therapeutics and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for mRNA therapeutics...
Outlook on the Antisense Oligonucleotide Therapeutics Global Market to 2030 - Featuring Biogen, Bio-Path Holdings and Sarepta Therapeutics Among Others
April 01, 2021 05:48 ET
|
Research and Markets
Dublin, April 01, 2021 (GLOBE NEWSWIRE) -- The "Antisense Oligonucleotide Therapeutics Market by Target Indication, Type of Therapy, Type of Molecule Type of Generation and Key Geographies: Industry...
Global CNS Specific Antisense Oligonucleotide Market to Surpass US$ 6.8 Billion by 2026 – Coherent Market Insights
February 08, 2019 08:30 ET
|
CMI
SEATTLE, Feb. 08, 2019 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global CNS specific antisense oligonucleotide market is valued at US$ 883.7 million in 2017, and is projected to...
GeneTx Biotherapeutics receives FDA orphan-drug designation for Angelman syndrome treatment
March 27, 2018 13:26 ET
|
GeneTx Biotherapeutics LLC.
DOWNERS GROVE, Ill., March 27, 2018 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration has granted orphan-drug designation to GeneTx Biotherapeutics LLC’s GTX-101 for the treatment of...